Session Information
2008 Midyear Clinical Meeting
Click here to go to the previous page
Antithrombotics: Clinical Challenges in Special Populations
Track:
Educational Sessions
Program Code: 285-L01
Date: Wednesday, December 10, 2008
Time: 4:00 PM to 5:00 PM EST
Location:
W203C
MEETING PLANNING ASSOCIATE:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Daniel Cobaugh, PharmD, FAACT, Director of Research and Program Development, ASHP Research and Education Foundation
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Daniel Cobaugh, PharmD, FAACT, Director of Research and Program Development, ASHP Research and Education Foundation- Describe the prevalence of venous thromboembolism in a pediatric population.
- Discuss differences in clinical outcomes in patients between direct thrombin inhibitors in the treatment of heparin-induced thrombocytopenia in patients who receive hemodialysis.
- Discuss the implementation of a venous thromboembolism risk assessment tool in a pediatric population.
- Discuss the use of once daily vs. twice daily enoxaparin in patients who have experienced a traumatic injury.